A Comparison of Vasopressin and Epinephrine for Out-of-Hospital Cardiopulmonary Resuscitation

New England Journal of Medicine

Volumn 350, Issue 2, 2004, Pages 105-113

  Wenzel, Volker ^a   Krismer, Anette C ^a   Arntz, H Richard ^b   Sitter, Helmut ^c   Stadlbauer, Karl H ^a   Lindner, Karl H ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

^c PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; AMIODARONE; ATROPINE; BICARBONATE; HYPERTENSIVE AGENT; LIDOCAINE; VASOPRESSIN;

ADULT; AGED; ARTICLE; ASYSTOLE; BRAIN FUNCTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORRELATION ANALYSIS; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; ELECTRIC ACTIVITY; EMERGENCY HEALTH SERVICE; FEMALE; FIBRINOLYSIS; GOOD CLINICAL PRACTICE; HEART ARREST; HEART ELECTROPHYSIOLOGY; HEART MUSCLE REFRACTORY PERIOD; HEART RHYTHM; HEART VENTRICLE FIBRILLATION; HOSPITAL; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; INJECTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; PULSELESS ELECTRICAL ACTIVITY; RANDOMIZED CONTROLLED TRIAL; RESUSCITATION; STATISTICAL SIGNIFICANCE; SURVIVAL; TREATMENT INDICATION; TREATMENT OUTCOME;

AGED; CARDIOPULMONARY RESUSCITATION; DRUG THERAPY, COMBINATION; EMERGENCY MEDICAL SERVICES; EPINEPHRINE; FEMALE; HEART ARREST; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; SURVIVAL RATE; SYMPATHOMIMETICS; VASOCONSTRICTOR AGENTS; VASOPRESSINS; VENTRICULAR FIBRILLATION;

EID: 0347086145     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMoa025431     Document Type: Article

References (30)

1. Gottlieb R. Ueber die Wirkung der Nebennieren Extracte auf Herz und Blutdruck. Arch Exp Path Pharmakol 1896-97;38:99-112.
2. Paradis NA, Wenzel V, Southall J. Pressor drugs in the treatment of cardiac arrest. Cardiol Clin 2002;20:61-78.
3. Lindner KH, Strohmenger HU, Ensinger H, Hetzel WD, Ahnefeld FW, Georgieff M. Stress hormone response during and after cardiopulmonary resuscitation. Anesthesiology 1992;77:662-8.
4. Lindner KH, Prengel AW, Pfenninger EG, et al. Vasopressin improves vital organ blood flow during closed-chest cardiopulmonary resuscitation in pigs. Circulation 1995;91: 215-21.
5. Prengel AW, Lindner KH, Keller A. Cerebral oxygenation during cardiopulmonary resuscitation with epinephrine and vasopressin in pigs. Stroke 1996;27:1241-8.
6. Wenzel V, Lindner KH, Prengel AW, et al. Vasopressin improves vital organ blood flow after prolonged cardiac arrest with post-countershock pulseless activity in pigs. Crit Care Med 1999;27:486-92.
7. Wenzel V, Lindner KH, Krismer AC, Miller EA, Voelckel WG, Lingnau W. Repeated administration of vasopressin but not epinephrine maintains coronary perfusion pressure after early and late administration during prolonged cardiopulmonary resuscitation in pigs. Circulation 1999;99:1379-84.
8. Wenzel V, Lindner KH, Krismer AC, et al. Survival with full neurologic recovery and no cerebral pathology after prolonged cardiopulmonary resuscitation with vasopressin in pigs. J Am Coll Cardiol 2000;35:527-33.
9. Lindner KH, Dirks B, Strohmenger HU, Prengel AW, Lindner IM, Lurie KG. Randomised comparison of epinephrine and vasopressin in patients with out-of-hospital ventricular fibrillation. Lancet 1997;349:535-7.
10. Guidelines 2000 for cardiopulmonary resuscitation and emergency cardiovascular care: international consensus on science. Circulation 2000;102: Suppl:I-1-I-384.
11. Guidelines 2000 for cardiopulmonary resuscitation and emergency cardiovascular care: an international consensus on science. Resuscitation 2000;46:1-447.
12. Human Medicines Evaluation Unit. Note for guidance on good clinical practice (Clinical Practice Medicinal Products [CPMP]/International Conference on Harmonization [ICH]/135/95). In: Guidelines for good clinical practice. ICH topic E6. London: European Agency for the Evaluation of Medicinal Products, 1995:1-58.
13. Cummins RO, Chamberlain DA, Abramson NS, et al. Recommended guidelines for uniform reporting of data from out-of-hospital cardiac arrest: the Utstein Style: a statement for health professionals from a task force of the American Heart Association, the European Resuscitation Council, the Heart and Stroke Foundation of Canada, and the Australian Resuscitation Council. Circulation 1991;84:960-75.
14. The Brain Resuscitation Clinical Trial II Study Group. A randomized clinical trial of calcium entry blocker administration to comatose survivors of cardiac arrest: design, methods, and patient characteristics. Control Clin Trials 1991;12:525-45.
15. Schneider T, Martens PR, Paschen H, et al. Multicenter, randomized, controlled trial of 150-J biphasic shocks compared with 200-to 3604 monophasic shocks in the resuscitation of out-of-hospital cardiac arrest victims. Circulation 2000;102:1780-7.
16. Babar SI, Berg RA, Hilwig RW, Kern KB, Ewy GA. Vasopressin versus epinephrine during cardiopulmonary resuscitation: a randomized swine outcome study. Resuscitation 1999;41:185-92.
17. Berg RA, Otto CW, Kem KB, et al. High-dose epinephrine results in greater early mortality after resuscitation from prolonged cardiac arrest in pigs: a prospective, randomized study. Crit Care Med 1994;22:282-90.
18. Fox AW, May RE, Mitch WE. Comparison of peptide and nonpeptide receptor-mediated responses in rat tail artery. J Cardiovasc Pharmacol 1992;20:282-9.
19. Paradis NA, Martin GB, Rivers EP, et al. Coronary perfusion pressure and the return of spontaneous circulation in human cardiopulmonary resuscitation. JAMA 1990; 263:1106-13.
20. Mayr VD, Wenzel V, Voelckel WG, et al. Developing a vasopressor combination in a pig model of adult asphyxial cardiac arrest. Circulation 2001;104:1651-6.
21. Stiell IG, Hébert PC, Wells GA, et al. Vasopressin versus epinephrine for in hospital cardiac arrest: a randomised controlled trial. Lancet 2001;358:105-9.
22. Morris DC, Dereczyk BE, Grzybowski M, et al. Vasopressin can increase coronary perfusion pressure during human cardiopulmonary resuscitation. Acad Emerg Med 1997;4: 878-83.
23. Lindner KH, Prengel AW, Brinkmann A, Strohmenger HU, Lindner IM, Lurie KG. Vasopressin administration in refractory cardiac arrest. Ann Intern Med 1996; 124:1061-4.
24. Grmec Š, Kamenik B, Mally Š, et al. Vasopressin in refractory out-of-hospital ventricular fibrillation: preliminary results. Crit Care 2002;6:Suppl 1:P162. abstract.
25. The Hypothermia after Cardiac Arrest Study Group. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med 2002;346:549-56. [Erratum, N Engl J Med 2002;346:1756.]
26. The Hypothermia after Cardiac Arrest Study Group. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med 2002;346:549-56. [Erratum, N Engl J Med 2002;346:1756.]
27. Eisenberg MS, Mengert TJ. Cardiac resuscitation. N Engl J Med 2001;344:1304-13.
28. Hallstrom A, Cobb L, Johnson E, Copass M. Cardiopulmonary resuscitation by chest compression alone or with mouth-to-mouth ventilation. N Engl J Med 2000;342:1546-53.
29. Kudenchuk PJ, Cobb LA, Copass MK, et al. Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation. N Engl J Med 1999;341:871-8.
30. Böttiger BW, Bode C, Kern S, et al. Efficacy and safety of thrombolytic therapy after initially unsuccessful cardiopulmonary resuscitation: a prospective clinical trial. Lancet 2001;357:1583-5.